1. Home
  2. GPUS vs XBIO Comparison

GPUS vs XBIO Comparison

Compare GPUS & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • XBIO
  • Stock Information
  • Founded
  • GPUS 1969
  • XBIO N/A
  • Country
  • GPUS United States
  • XBIO United States
  • Employees
  • GPUS N/A
  • XBIO N/A
  • Industry
  • GPUS
  • XBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • XBIO Health Care
  • Exchange
  • GPUS NYSE
  • XBIO Nasdaq
  • Market Cap
  • GPUS 7.6M
  • XBIO 6.3M
  • IPO Year
  • GPUS 1996
  • XBIO N/A
  • Fundamental
  • Price
  • GPUS $5.81
  • XBIO $4.06
  • Analyst Decision
  • GPUS
  • XBIO Hold
  • Analyst Count
  • GPUS 0
  • XBIO 1
  • Target Price
  • GPUS N/A
  • XBIO N/A
  • AVG Volume (30 Days)
  • GPUS 152.6K
  • XBIO 22.9K
  • Earning Date
  • GPUS 11-19-2024
  • XBIO 11-12-2024
  • Dividend Yield
  • GPUS N/A
  • XBIO N/A
  • EPS Growth
  • GPUS N/A
  • XBIO N/A
  • EPS
  • GPUS N/A
  • XBIO N/A
  • Revenue
  • GPUS $139,425,000.00
  • XBIO $2,523,427.00
  • Revenue This Year
  • GPUS N/A
  • XBIO N/A
  • Revenue Next Year
  • GPUS N/A
  • XBIO N/A
  • P/E Ratio
  • GPUS N/A
  • XBIO N/A
  • Revenue Growth
  • GPUS 3.50
  • XBIO 7.15
  • 52 Week Low
  • GPUS $4.98
  • XBIO $2.78
  • 52 Week High
  • GPUS $111.08
  • XBIO $5.20
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • XBIO 47.20
  • Support Level
  • GPUS N/A
  • XBIO $3.92
  • Resistance Level
  • GPUS N/A
  • XBIO $4.27
  • Average True Range (ATR)
  • GPUS 0.00
  • XBIO 0.27
  • MACD
  • GPUS 0.00
  • XBIO -0.05
  • Stochastic Oscillator
  • GPUS 0.00
  • XBIO 19.09

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.

Share on Social Networks: